Osteocytes: Central conductors of bone biology in normal and pathological conditions

Acta Physiologica

Volumn 204, Issue 3, 2012, Pages 317-330

  Neve, A ^a   Corrado, A ^a   Cantatore, F P ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Bone disease; Machanotransduction; Osteocytes

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; CALCITRIOL RECEPTOR; COLLAGENASE 3; DENTIN MATRIX PROTEIN 1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; EXCITATORY AMINO ACID TRANSPORTER 1; FIBROBLAST GROWTH FACTOR 23; GELATINASE A; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; NITRIC OXIDE; OSTEOCALCIN; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PROSTAGLANDIN E2; SCLEROSTIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; WNT PROTEIN;

BONE DENSITY; BONE MINERALIZATION; BONE REMODELING; BONE TURNOVER; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL METABOLISM; CELL STRUCTURE; CELL VIABILITY; EXTRACELLULAR MATRIX; HUMAN; MECHANICAL STIMULATION; MICROENVIRONMENT; NONHUMAN; OSSIFICATION; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PHAGOCYTOSIS; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DISEASES; BONE REMODELING; CELL DEATH; CELL DIFFERENTIATION; HUMANS; MECHANOTRANSDUCTION, CELLULAR; OSTEOCYTES; OSTEOGENESIS;

EID: 84856552724     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02385.x     Document Type: Review

References (128)

1. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. 1997. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J16, 3797-3804.
2. Adachi, T., Aonuma, Y., Tanaka, M., Hojo, M., Takano-Yamamoto, T. & Kamioka, H. 2009. Calcium response in single osteocytes to locally applied mechanical stimulus: differences in cell process and cell body. J Biomech42, 1989-1995.
3. Addison, W.N., Nakano, Y., Loisel, T., Crine, P. & McKee, M.D. 2008. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res23, 1638-1649.
4. Aguirre, J.I., Plotkin, L.I., Stewart, S.A., Weinstein, R.S., Parfitt, A.M., Manolagas, S.C. & Bellido, T. 2006. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res21, 605-615.
5. Al-Dujaili, S.A., Lau, E., Al-Dujaili, H., Tsang, K., Guenther, A. & You, L. 2011. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. J Cell Biochem112, 2412-2423.
6. Altman, R.D. 2001. Paget's disease of bone. In: Koopman. WJ (ed.) Arthritis and Allied Conditions, 14th edn. pp. 2514-2527. Lippincott Williams Wilkins, Philadelphia.
7. Atkins, G.J., Rowe, P.S., Lim, H.P., Welldon, K.J., Ormsby, R., Wijenayaka, A.R., Zelenchuk, L., Evdokiou, A. & Findlay, D.M. 2011. Sclerostin is a locally acting regulator of late-osteoblast/pre-osteocyte differentiation and regulates mineralization through a MEPE-ASARM dependent mechanism. J Bone Miner Res26, 1425-1436.
8. Bacabac, R.G., Mizuno, D., Schmidt, C.F., MacKintosh, F.C., Van Loon, J.J., Klein-Nulend, J. & Smith, T.H. 2008. Round versus flat: bone cell morphology, elasticity, and mechanosensing. J Biomech41, 1590-1598.
9. Balemans, W., Ebeling, M., Patel, N., Van Hul, E., Olson, P., Dioszegi, M., Lacza, C., Wuyts, W., Van Den Ende, J., Willems, P.et al.2001. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet10, 537-543.
10. Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F.G., Hildering, P., Willems, P.J., Verheij, J.B., Lindpaintner, K., Vickery, B., Foernzler, D. & Van Hul, W. 2002. Identification of a 52kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet39, 91-97.
11. Baud, C.A. 1962. Morphology and inframicroscopic structure of osteocytes. Acta Anat (Basel)51, 209-225.
12. Beavan, S., Horner, A., Bord, S., Ireland, D. & Compston, J. 2001. Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J Bone Miner Res16, 1496-1504.
13. Beil, F.T., Seitz, S., Priemel, M., Barvencik, F., Von Domuras, C., Rueger, J.M., Amling, M. & Podoga, P. 2008. Pathophysiology and pathomorphology of osteoporosis. Eur J Trauma Emerg Surg6, 527-534.
14. Belanger, L., Robichin, J., Migicovsky, B., Coop, D. & Vincent, J. 1963. Resorption without osteoclasts (osteolysis). In: Sognaes.R (ed.) Mechanism of Hard Tissue Destruction. pp. 531-556. American Association for the Advancement of Science, Washington DC.
15. Ben-Dov, I.Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T. & Silver, J. 2007. The parathyroid is a target organ for FGF23 in rats. J Clin Invest117, 4003-4008.
16. Bliziotes, M., Eshleman, A., Burt-Pichat, B., Zhang, X.W., Hashimoto, J., Wiren, K. & Chenu, C. 2006. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone39, 1313-1321.
17. Boivin, G., Mesguich, P., Pike, J.W., Bouillon, R., Meunier, P.J., Haussler, M.R., Dubois, P.M. & Morel, G. 1987. Ultrastructural immunocytochemical localization of endogenous 1, 25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria. Bone Miner3, 125-136.
18. Bonewald, L.F. & Johnson, M.L. 2008. Osteocytes, mechanosensing and Wnt signaling. Bone42, 606-615.
19. Bonucci, E., Gherardi, G. & Faraggiana, T. 1976. Bone changes in hemodialyzed uremic subjects. Comparative light and electron microscope investigations. Virchows Arch A Pathol Anat Histol371, 183-198.
20. Bord, S., Horner, A., Beavan, S. & Compston, J. 2001. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab86, 2309-2314.
21. Braidman, I.P., Davenport, L.K., Carter, D.H., Selby, P.L., Mawer, E.B. & Freemont, A.J. 1995. Preliminary in situ identification of estrogen target cells in bone. J Bone Miner Res10, 74-80.
22. Braidman, I.P., Hainey, L., Batra, G., Selby, P.L., Saunders, P.T. & Hoyland, J.A. 2001. Localization of estrogen receptor beta protein expression in ault human bone. J Bone Miner Res16, 214-220.
23. Brennan, O., Kennedy, O.D., Lee, T.C., Rackard, S.M. & O'Brien, F.J. 2011. Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis. J Orthop Res29, 419-424.
24. Busse, B., Djonic, D., Milovanovic, P., Hahn, M., Püschel, K., Ritchie, R.O., Djuric, M. & Amling, M. 2010. Decrease in the osteocyte lacunar density accompained by hipermineralized lacunar occlusion reveals failure and delay of remodeling in aged human bone. Aging Cell9, 1065-1075.
25. Butler, W.T., Ritchie, H.H. & Bronckers, A.L. 1997. Extracellular matrix proteins of dentine. Ciba Found Symp205, 107-117.
26. Chow, J.W., Fox, S., Jagger, C.J. & Chambers, T.J. 1998. Role for parathyroid hormone in mechanical responsiveness of rat bone. Am J Physiol274, E146-E154.
27. Cowin, S.C., Weinbaum, S. & Zeng, Y. 1995. A case for bone canaliculi as the anatomical site of strain generated potentials. J Biomech28, 1281-1297.
28. Dudley, H.R. & Spiro, D. 1961. The fine structure of bone cells. J Biophys Biochem Cytol11, 627-649.
29. Dunstan, C.R., Somers, N. & Evans, R. 1993. Osteocyte death and hip fractures. Calcif Tissue Int53, S113-S117.
30. Elmardi, A.S., Katchburian, M.V. & Katchburian, E. 1990. Electron microscopy of developing calvaria reveals images that suggest that osteoclasts engulf and destroy osteocytes during bone resorption. Calcif Tissue Int46, 239-245.
31. Emerton, K.B., Hu, B., Woo, A.A., Sinofsky, A., Hernandez, C., Majeska, R.J., Jepsen, K.J. & Schaffler, M.B. 2010. Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone46, 577-583.
32. Falchetti, A., Marini, F., Masi, L., Amedei, A. & Brandi, M.L. 2010. Genetic aspects of the Paget's disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application. Eur J Clin Invest40, 655-667.
33. Fan, X., Roy, E., Zhu, L., Murphy, T.C., Ackert-Bicknell, C., Hart, C.M., Rosen, C., Nanes, M.S. & Rubin, J. 2004. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology145, 751-759.
34. Feng, J.Q., Ward, L.M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S.I., Zhang, S., Rios, H., Drezner, M.K., Quarles, L.D., Bonewald, L.F. & White, K.E. 2006. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet38, 1310-1315.
35. Fliser, D., Kollerits, B., Neyer, U., Ankerst, D.P., Lhotta, K., Lingenhel, A., Ritz, E., Kronenberg, F., MMKD Study Group, Kuen, E.et al.2007. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol18, 2600-2608.
36. Fonseca, H., Moreira-Gonçalves, D., Esteves, J.L., Viriato, N., Vaz, M., Mota, M.P. & Duarte, J.A. 2011. Voluntary exercise has long-term in vivo protective effects on osteocyte viability and bone strength following ovariectomy. Calcif Tissue Int88, 443-454.
37. Gattineni, J., Bates, C., Twombley, K., Dwarakanath, V., Robinson, M.L., Goetz, R., Mohammadi, M. & Baum, M. 2009. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol297, F282-F291.
38. Gluhak-Heinrich, J., Pavlin, D., Yang, W., MacDougall, M. & Harris, S.E. 2007. MEPE expression in osteocytes during orthodontic tooth movement. Arch Oral Biol52, 684-690.
39. Gu, G., Mulari, M., Peng, Z., Hentunen, T.A. & Väänänen, H.K. 2005. Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption. Biochem Biophys Res Commun335, 1095-1101.
40. Gu, G., Nars, M., Hentunen, T.A., Metsikkö, K. & Väänänen, H.K. 2006. Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res323, 263-271.
41. Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Jüppner, H. & Wolf, M. 2005. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol16, 2205-2215.
42. Harris, S.E., Gluhak-Heinrich, J., Harris, M.A., Yang, W., Bonewald, L.F., Riha, D., Rowe, P.S., Robling, A.G., Turner, C.H., Feng, J.Q., McKee, M.D. & Nicollela, D. 2007. DMP1 and MEPE expression are elevated in osteocytes after mechanical loading in vivo: theoretical role in controlling mineral quality in the perilacunar matrix. J Musculoskelet Neuronal Interact7, 313-315.
43. Hatori, K., Sasano, Y., Takahashi, I., Kamakura, S., Kagayama, M. & Sasaki, K. 2004. Osteoblasts and osteocytes express MMP2 and -8 and TIMP1, -2, and -3 along with extracellular matrix molecules during appositional bone formation. Anat Rec A Discov Mol Cell Evol Biol277, 262-271.
44. Hino, S., Tanji, C., Nakayama, K.I. & Kikuchi, A. 2005. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitation. Mol Cell Biol25, 9063-9072.
45. van Hove, R.P., Nolte, P.A., Vatsa, A., Semeins, C.M., Salmon, P.L., Smit, T.H. & Klein-Nulend, J. 2009. Osteocyte morphology in human tibiae of different bone pathologies with different bone mineral density - is there a role for mechanosensing? Bone 45, 321-329.
46. Huggett, J.F., Mustafa, A., O'neal, L. & Mason, D.J. 2002. The glutamate transporter GLAST-1 (EAAT-1) is expressed in the plasma membrane of osteocytes and is responsive to extracellular glutamate concentration. Biochem Soc Trans30, 890-893.
47. Hughes, D.E., Dai, A., Tiffee, J.C., Li, H.H., Mundy, G.R. & Boyce, B.F. 1996. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med2, 1132-1136.
48. Inoue, K., Mikuni-Takagaki, Y., Oikawa, K., Itoh, T., Inada, M., Noguchi, T., Park, J.S., Onodera, T., Krane, S.M., Noda, M. & Itohara, S. 2006. A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J Biol Chem281, 33814-33824.
49. Kalajzic, I., Braut, A., Guo, D., Jiang, X., Kronenberg, M.S., Mina, M., Harris, M.A., Harris, S.E. & Rowe, D.W. 2004. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone35, 74-82.
50. Kamioka, H., Sugawara, Y., Honjo, T., Yamashiro, T. & Takano-Yamamoto, T. 2004. Terminal differentiation of osteoblasts to osteocytes is accompanied by dramatic changes in the distribution of actin-binding proteins. J Bone Miner Res19, 471-478.
51. Kamiya, N. & Takagi, M. 2001. Differential expression of dentin matrix protein 1, type I collagen and osteocalcin genes in rat developing mandibular bone. Histochem J33, 545-552.
52. Kato, Y., Windle, J.J., Koop, B.A., Mundy, G.R. & Bonewald, L.F. 1997. Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res12, 2014-2023.
53. Kawata, T., Imanishi, Y., Kobayashi, K., Miki, T., Arnold, A., Inaba, M. & Nishizawa, Y. 2007. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol18, 2683-2688.
54. Kitase, Y., Barragan, L., Qing, H., Kondoh, S., Jiang, J.X., Johnson, M.L. & Bonewald, L.F. 2010. Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways. J Bone Miner Res25, 2657-2668.
55. Knothe Tate, M.L. 2003. "Whither flows the fluid in bone?" An osteocyte's perspective. J Biomech36, 1409-1424.
56. Krempien, B. & Ritz, E. 1978. Effects of parathyroid hormone on osteocytes. Ultrastructural evidence for anisotropic osteolysis and involvement of the cytoskeleton. Metab Bone Dis Relat Res1, 55-65.
57. Kulkarni, R.N., Bakker, A.D., Everts, V. & Klein-Nulend, J. 2010. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE. Calcif Tissue Int87, 461-468.
58. Lane, N.E., Yao, W., Balooch, M., Nalla, R.K., Balooch, G., Habelitz, S., Kinney, J.H. & Bonewald, L.F. 2006. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res21, 466-476.
59. Larsson, T., Marsell, R., Schipani, E., Ohlsson, C., Ljunggren, O., Tenenhouse, H.S., Jüppner, H. & Jonsson, K.B. 2004. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology145, 3087-3094.
60. Lee, K.C., Jessop, H., Suswillo, R., Zaman, G. & Lanyon, L.E. 2004. The adaptive response of bone to mechanical loading in female transgenic mice is deficient in the absence of oestrogen receptor-alpha and -beta. J Endocrinol182, 193-201.
61. Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S.E. & Wu, D. 2005. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem280, 19883-19887.
62. Li, X., Ominsky, M.S., Warmington, K.S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R.et al.2009. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res24, 578-588.
63. Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D.W. & Quarles, L.D. 2006. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab291, E38-E49.
64. Liu, S., Rowe, P.S., Vierthaler, L., Zhou, J. & Quarles, L.D. 2007. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity. J Endocrinol192, 261-267.
65. Liu, X.H., Kirschenbaum, A., Weinstein, B.M., Zaidi, M., Yao, S. & Levine, A.C. 2010. Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells. Biochem Biophys Res Commun394, 715-720.
66. Lorenz-Depiereux, B., Bastepe, M., Benet-Pagès, A., Amyere, M., Wagenstaller, J., Müller-Barth, U., Badenhoop, K., Kaiser, S.M., Rittmaster, R.S., Shlossberg, A.H.et al.2006. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet38, 1248-1250.
67. Lu, Y., Qin, C., Xie, Y., Bonewald, L.F. & & Feng, J.Q. 2009. Studies of the DMP1 57-kDa functional domain both in vivo and in vitro. Cells Tissues Organs189, 175-185.
68. Lu, Y., Yuan, B., Qin, C., Cao, Z., Xie, Y., Dallas, S.L., McKee, M.D., Drezner, M.K., Bonewald, L.F. & Feng, J.Q. 2011. The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment. J Bone Miner Res26, 331-340.
69. Ma, Y., Jee, W.S., Yuan, Z., Wei, W., Chen, H., Pun, S., Liang, H. & Lin, C. 1999. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal corticalbone. J Bone Miner Res14, 439-448.
70. Mann, V., Huber, C., Kogianni, G., Jones, D. & Noble, B. 2006. The influence of mechanical stimulation on osteocyte apoptosis and bone viability in human trabecular bone. J Musculoskelet Neuronal Interact6, 408-417.
71. Manolagas, S.C., Weinstein, R.S., Bellido, T. & Bodenner, D.L. 1999. Opposite effects of estrogen on the life span of osteoblasts/osteocytes vs. osteoclasts in vivo and in vitro: an explanation of the imbalance between formation and resorption in estrogen deficiency. J Bone Miner Res14, S169.
72. Marotti, G., Zallone, A.Z. & Ledda, M. 1976. Number, size and arrangement of osteoblasts in osteons at different stages of formation. Calcif Tissue Res21(Suppl), 96-101.
73. Mason, D.J., Suva, L.J., Genever, P.G., Patton, A.J., Steuckle, S., Hillam, R.A. & Skerry, T.M. 1997. Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? Bone 20, 199-205.
74. McNamara, L.M., Majeska, R.J., Weinbaum, S., Friedrich, V. & Schaffler, M.B. 2009. Attachment of osteocyte cell processes to the bone matrix. Anat Rec (Hoboken)292, 355-363.
75. Mercer, R.R. & Crenshaw, M.A. 1985. The role of osteocytes in bone resorption during lactation: morphometric observations. Bone6, 269-274.
76. Mirza, F.S., Padhi, I.D., Raisz, L.G. & Lorenzo, J.A. 2010. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab95, 1991-1997.
77. Murray, A.B., Schmidt, J. & Rieke, L. 1986. Retrovirus-induced osteopetrosis in mice. Ultrastructural evidence of early virus production in osteoblasts and osteocytes. Am J Pathol124, 319-323.
78. Nakamura, H., Sato, G., Hirata, A. & Yamamoto, T. 2004. Immunolocalization of matrix etalloproteinase-13 on bone surface under osteoclasts in rat tibia. Bone34, 48-56.
79. Nakano, Y., Toyosawa, S. & Takano, Y. 2004. Eccentric localization of osteocytes expressing enzymatic activities, protein, and mRNA signals for type 5 tartrate-resistant acid phosphatase (TRAP). J Histochem Cytochem52, 1475-1482.
80. Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., Feng, J.Q., Bonewald, L.F., Kodama, T., Wutz, A., Wagner, E.F., Penninger, J.M. & Takayanagi, H. 2011. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med17, 1231-1234.
81. Nampei, A., Hashimoto, J., Hayashida, K., Tsuboi, H., Shi, K., Tsuji, I., Miyashita, H., Yamada, T., Matsukawa, N., Matsumoto, M., Morimoto, S., Ogihara, T., Ochi, T. & Yoshikawa, H. 2004. Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone. J Bone Miner Metab22, 176-184.
82. O'Brien, C.A., Jia, D., Plotkin, L.I., Bellido, T., Powers, C.C., Stewart, S.A., Manolagas, S.C. & Weinstein, R.S. 2004. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology145, 1835-1841.
83. O'Brien, C.A., Plotkin, L.I., Galli, C., Goellner, J.J., Gortazar, A.R., Allen, M.R., Robling, A.G., Bouxsein, M., Schipani, E., Turner, C.H., Jilka, R.L., Weinstein, R.S., Manolagas, S.C. & Bellido, T. 2008. Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS ONE3, e2942.
84. van Oers, R.F., Ruimerman, R., Tanck, E., Hilbers, P.A. & Huiskes, R. 2008. A unified theory for osteonal and hemi-osteonal remodeling. Bone42, 250-259.
85. Ohashi, T., Kusuhara, S. & Ishida, K. 1991. Immunoelectron microscopic demonstration of estrogen receptors in osteogenic cells of Japanese quail. Histochemistry96, 41-44.
86. Palumbo, C. 1986. A three-dimensional ultrastructural study of osteoid-osteocytes in the tibia of chick embryos. Cell Tissue Res246, 125-131.
87. Parfitt, A.M. 1977. The cellular basis of bone turnover and bone loss: a rebuttal of the osteocytic resorption - bone flow theory. Clin Orthop Relat Res127, 236-247.
88. Parfitt, A.M., Mundy, G.R., Roodman, G.D., Hughes, D.E. & Boyce, B.F. 1996. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res11, 150-159.
89. Paznekas, W.A., Boyadjiev, S.A., Shapiro, R.E., Daniels, O., Wollnik, B., Keegan, C.E., Innis, J.W., Dinulos, M.B., Christian, C., Hannibal, M.C. & Jabs, E.W. 2003. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet72, 408-418.
90. Pereira, R.C., Juppner, H., Azucena-Serrano, C.E., Yadin, O., Salusky, I.B. & Wesseling-Perry, K. 2009. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone45, 1161-1168.
91. Powell, W.F. Jr, Barry, K.J., Tulum, I., Kobayashi, T., Harris, S.E., Bringhurst, F.R. & Pajevic, P.D. 2011. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol209, 21-32.
92. Qing, H. & Bonewald, L.F. 2009b. Osteocyte remodeling of the perilacunar and pericanalicular matrix. Int J Oral Sci1, 59-65.
93. Qing, H., Ardeshirpour, L., Dusevich, V., Wysolmerski, J. & Bonewald, L.F. 2009a. Osteocyte Perilacunar Remodeling Is Regulated Hormonally, but Not by Mechanical Unloading. J Bone Miner Res (Suppl 1), MO0255.
94. Rath, A.L., Bonewald, L.F., Ling, J., Jiang, J.X., Van Dyke, M.E. & Nicolella, D.P. 2010. Correlation of cell strain in single osteocytes with intracellular calcium, but not intracellular nitric oxide, in response to fluid flow. J Biomech43, 1560-1564.
95. Rhee, Y., Allen, M.R., Condon, K., Lezcano, V., Ronda, A.C., Galli, C., Olivos, N., Passeri, G., O'Brien, C.A., Bivi, N., Plotkin, L.I. & Bellido, T. 2011a. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling. J Bone Miner Res26, 1035-1046.
96. Rhee, Y., Bivi, N., Farrow, E., Lezcano, V., Plotkin, L.I., White, K.E. & Bellido, T. 2011b. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone49, 636-643.
97. Robling, A.G., Niziolek, P.J., Baldridge, L.A., Condon, K.W., Allen, M.R., Alam, I., Mantila, S.M., Gluhak-Heinrich, J., Bellido, T.M., Harris, S.E. & Turner, C.H. 2008. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem283, 5866-5875.
98. Rochefort, G.Y., Pallu, S. & Benhamou, C.L. 2010. Osteocyte: the unrecognized side of bone tissue. Osteoporos Int21, 1457-1469.
99. Rowe, P.S., Garrett, I.R., Schwarz, P.M., Carnes, D.L., Lafer, E.M., Mundym, G.R. & Gutierrez, G.E. 2005. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone36, 33-46.
100. Sakagami, N., Amizuka, N., Li, M., Takeuchi, K., Hoshino, M., Nakamura, M., Nozawa-Inoue, K., Udagawa, N. & Maeda, T. 2005. Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice. Micron36, 688-695.
101. Sasano, Y., Zhu, J.X., Tsubota, M., Takahashi, I., Onodera, K., Mizoguchi, I. & Kagayama, M. 2002. Gene expression of MMP8 and MMP13 during embryonic development of bone and cartilage in the rat mandible and hind limb. J Histochem Cytochem50, 325-332.
102. Shimada, T., Muto, T., Urakawa, I., Yoneya, T., Yamazaki, Y., Okawa, K., Takeuchi, Y., Fujita, T., Fukumoto, S. & Yamashita, T. 2002. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology143, 3179-3182.
103. Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., Fujita, T., Nakahara, K., Fukumoto, S. & Yamashita, T. 2004a. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res19, 429-435.
104. Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K. & Yamashita, T. 2004b. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest113, 561-568.
105. Shiraki, M., Gee, M.V., Baum, B.J. & Roth, G.S. 1986. Parathyroid hormone stimulates phosphate efflux through an apparently adenosine 3′, 5′-monophosphate-independent process in rat parotid cell aggregates. Endocrinology118, 2009-2015.
106. Stanislaus, D., Yang, X., Liang, J.D., Wolfe, J., Cain, R.L., Onyia, J.E., Falla, N., Marder, P., Bidwell, J.P., Queener, S.W. & Hock, J.M. 2000. In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. Bone27, 209-218.
107. Steinbrech, D.S., Mehrara, B.J., Rowe, N.M., Dudziak, M.E., Luchs, J.S., Saadeh, P.B., Gittes, G.K. & Longaker, M.T. 2000. Gene expression of TGF-beta, TGF-beta receptor, and extracellular matrix proteins during membranous bone healing in rats. Plast Reconstr Surg105, 2028-2038.
108. Sugawara, Y., Kamioka, H., Honjo, T., Tezuka, K. & Takano-Yamamoto, T. 2005. Three-dimensional reconstruction of chick calvarial osteocytes and their cell processes using confocal microscopy. Bone36, 877-883.
109. Talmage, R.V., Doppelt, S.H. & Fondren, F.B. 1976. An interpretation of acute changes in plasma 45Ca following parathyroid hormone administration to thyroparathyroidectomized rats. Calcif Tissue Res22, 117-128.
110. Tan, S.D., Vries, T.J., Kuijpers-Jagtman, A.M., Semeins, C.M., Everts, V. & Klein-Nulend, J. 2007. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption. Bone41, 745-751.
111. Tanaka-Kamioka, K., Kamioka, H., Ris, H. & Lim, S.S. 1998. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res13, 1555-1568.
112. Tatsumi, S., Ishii, K., Amizuka, N., Li, M., Kobayashi, T., Kohno, K., Ito, M., Takeshita, S. & Ikeda, K. 2007. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab5, 464-475.
113. Tazawa, K., Hoshi, K., Kawamoto, S., Tanaka, M., Ejiri, S. & Ozawa, H. 2004. Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered. J Bone Miner Metab22, 524-529.
114. Tomkinson, A., Reeve, J., Shaw, R.W. & Noble, B.S. 1997. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab82, 3128-3135.
115. Tomkinson, A., Gevers, E.F., Wit, J.M., Reeve, J. & Noble, B.S. 1998. The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res13, 1243-1250.
116. Toyosawa, S., Shintani, S., Fujiwara, T., Ooshima, T., Sato, A., Ijuhin, N. & Komori, T. 2001. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res16, 2017-2026.
117. Turner, C.H., Takano, Y., Owan, I. & Murrell, G.A. 1996. Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. Am J Physiol270, E634-E639.
118. Vatsa, A., Breuls, R.G., Semeins, C.M., Salmon, P.L., Smit, T.H. & Klein-Nulend, J. 2008. Osteocyte morphology in fibula and calvaria - is there a role for mechanosensing? Bone 43, 452-458.
119. Veno, P., Nicolella, D.P., Sivakumar, P., Kalajzic, I., Rowe, D., Harris, S.E., Bonewald, L.F. & Dallas, S.L. 2006. Live imaging of osteocytes within their lacunae reveals cell body and dendrite motions. J Bone Miner Res21(Suppl 1), S38.
120. Weinstein, R.S., Jilka, R.L., Almeida, M., Roberson, P.K. & Manolagas, S.C. 2010. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology151, 2641-2649.
121. Westbroek, I., van der Plas, A., de Rooij, K.E., Klein-Nulend, J. & Nijweide, P.J. 2001. Expression of serotonin receptors in bone. J Biol Chem276, 28961-28968.
122. Westendorf, J.J., Kahler, R.A. & Schroeder, T.N. 2004. Wnt signaling in osteoblasts and bone diseases. Gene341, 19-39.
123. Winkler, D.G., Sutherland, M.K., Geoghegan, J.C., Yu, C., Hayes, T., Skonier, J.E., Shpektor, D., Jonas, M., Kovacevich, B.R., Staehling-Hampton, K., Appleby, M., Brunkow, M.E. & Latham, J.A. 2003. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J22, 6267-6676.
124. Xiong, J., Onal, M., Jilka, R.L., Weinstein, R.S., Manolagas, S.C. & O'Brien, C.A. 2011. Matrix-embedded cells control osteoclast formation. Nat Med17, 1235-1241.
125. Yamamoto, R., Minamizaki, T., Yoshiko, Y., Yoshioka, H., Tanne, K., Aubin, J.E. & Maeda, N. 2010. 1alpha, 25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro. J Endocrinol206, 279-286.
126. Yellowley, C.E., Li, Z., Zhou, Z., Jacobs, C.R. & Donahue, H.J. 2000. Functional gap junctions between osteocytic and osteoblastic cells. J Bone Miner Res15, 209-217.
127. You, J., Yellowley, C.E., Donahue, H.J., Zhang, Y., Chen, Q. & Jacobs, C.R. 2000. Substrate deformation levels associated with routine physical activity are less stimulatory to bone cells relative to loading induced oscillating fluid flow. J Biomech Eng122, 387-393.
128. Yu, X., Sabbagh, Y., Davis, S.I., Demay, M.B. & White, K.E. 2005. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. Bone36, 971-977.